Member Exclusive

Probing the epigenome: interview with Dr Matthew Fuchter

As part of our focus on epigenetic drug discovery, MedChemNet spoke to Dr Matthew Fuchter (Imperial College London, UK) about his work in the field, including his perspective on the potential of epigenetic research in anti-cancer and anti-infective research.

Sep 01, 2016
0
0

Please sign in or register for FREE

No comments yet.